Pharmacy benefit manager (PBM) reform has emerged as a bipartisan priority in a divided Congress as both Republicans and Democrats have advanced a myriad of bills that would begin to address PBMs, their lack of transparency and misalignment of the market. At the same time, lobbyists that represent large PBMs continue to argue that drug companies (not integrated PBMs) are to blame for high employer or patient costs.

With so many complex ideas and possible solutions on the table, impacting taxpayers and businesses, how should Washington increase PBM accountability to make sure employees and patients aren’t overpaying for the prescription medicines they need? And what role will transparent PBMs coming to market – alongside all stakeholders in health care – play in driving change?

What does meaningful comprehensive PBM reform look like? And what incremental changes can Congress begin to make today and, in the future, to continue to improve the management of prescription drug benefits and ultimately reduce costs?

Join The Hill as we convene leaders and stakeholders in healthcare, government, business, pharmacy, and consumer patient advocacy to answer these questions and more.